产品信息
- Genetically modified cell lines best reflect MOA (Mechanism of Action)
- Higher activity and larger assay window for robust and reproducible cell-based bioassay
- Comprehensive application data to support assay development and validation
- Full tracible record, stringent quality control and validated cell passage stability
- Parental cell line legally obtained from internationally recognized cell resource bank and commercially licensed
- Global commercial license assistance whenever regulatory filing is required
描述(Description)
The HEK293/Human GPR75 Stable Cell Line was engineered to express the receptor full length human GPR75 (Gene ID: 10936), used to mimic cancer target cells. Surface expression of human GPR75 was confirmed by flow cytometry.
应用说明(Application)
• Useful for cell-based GPR75 binding assay
生长特性(Growth Properties)
Adherent
筛选标记(Selection Marker)
Puromycin (2 μg/mL)
培养基(Complete Growth Medium)
DMEM + 10% FBS
冻存液(Freeze Medium)
Serum-free cell cryopreservation medium
装量(Quantity)
1 vial contains at least 5×10^6 cells in 1 mL serum-free cryopreservation medium
存储(Storage)
Frozen in liquid nitrogen.
支原体检测(Mycoplasma Testing)
Negative
无菌检测(Sterility Testing)
Negative
使用说明(Instructions for Use)
See data sheet for detailed culturing and assay protocol.
产品数据图
Receptor Assay

Expression analysis of human GPR75 on HEK293/Human GPR75 Stable Cell Line by FACS.
Cell surface staining was performed on HEK293/Human GPR75 Stable Cell Line or negative control cell using anti-human GPR75 antibody followed by staining with FITC anti-mouse IgG antibody.
Protocol
产品评论 发表评论

背景
G protein-coupled receptor that is activated by the chemokine CCL5/RANTES. Probably coupled to heterotrimeric Gq proteins, it stimulates inositol trisphosphate production and calcium mobilization upon activation. Together with CCL5/RANTES, may play a role in neuron survival through activation of a downstream signaling pathway involving the PI3, Akt and MAP kinases. CCL5/RANTES may also regulate insulin secretion by pancreatic islet cells through activation of this receptor.